{
  "trials": [
    {
      "id": "CT001",
      "title": "抗肿瘤药物III期临床试验",
      "phase": 3,
      "status": "进行中",
      "participants": 450,
      "last_updated": "2024-03-20T09:00:00Z",
      "endpoints": {
        "primary": "总体生存率",
        "secondary": ["无进展生存期", "不良反应率"]
      }
    },
    {
      "id": "CT002",
      "title": "Amgen Phase II 减肥药临床试验",
      "phase": 2,
      "status": "已完成",
      "participants": 320,
      "last_updated": "2024-03-25T14:30:00Z",
      "endpoints": {
        "primary": "12周体重减轻百分比",
        "secondary": ["安全特性","代谢指标改善"]
      },
      "stock_impact": {
        "price_change": -12,
        "analysis": "尽管达到主要终点，因市场预期过高导致股价下跌"
      }
    }
  ],
  "changelog": []
}